Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026)
Zymeworks (ZYME) posted Goodwill & Intangibles of $13.2 million for Q1 2026, down 1.32% sequentially from $13.4 million in Q4 2025, and down 14.23% YoY from $15.4 million in Q1 2025.
Analysis
Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Zymeworks has reported Goodwill & Intangibles for 6 years, with the latest figure at $13.2 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 14.23% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (down 14.23% YoY) and the FY2025 annual result came in at $13.4 million, down 19.44% from the prior year.
- Goodwill & Intangibles eased to $13.2 million in Q1 2026 per ZYME's latest filing, from $13.4 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $29.6 million in Q4 2022 and troughed at $12.4 million in Q2 2024.
- A 5-year average of $18.4 million and a median of $18.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles sank 36.35% in 2024, then increased 13.79% in 2025.
- Over 5 years, Goodwill & Intangibles stood at $29.6 million in 2022, then tumbled by 33.64% to $19.7 million in 2023, then declined by 15.66% to $16.6 million in 2024, then retreated by 19.44% to $13.4 million in 2025, then retreated by 1.32% to $13.2 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $13.2 million, $13.4 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.01 Mn |
| Mar 31, 2026 | 13.19 Mn |
| Dec 31, 2025 | 13.37 Mn |
| Sep 30, 2025 | 13.41 Mn |
| Jun 30, 2025 | 14.06 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 16.59 Mn |
| Sep 30, 2024 | 18.42 Mn |
| Jun 30, 2024 | 19.13 Mn |
| Mar 31, 2024 | 29.64 Mn |
| Dec 31, 2023 | 29.64 Mn |
| Sep 30, 2023 | 29.64 Mn |
| Jun 30, 2023 | 29.64 Mn |
| Mar 31, 2023 | 29.64 Mn |
| Dec 31, 2022 | 29.64 Mn |
| Sep 30, 2022 | 29.64 Mn |
| Dec 31, 2021 | 29.64 Mn |